Table 9.
Analysis of In-Hospital Complications Across Different Fracture Patterns When Managed by ENT or PS.
| Complication, n (%) | ENT | PS | P value |
|---|---|---|---|
| Orbital floor fracture, n | 131 | 132 | |
| Malocclusion | 1 (0.8%) | 2 (1.5%) | 0.566 |
| Paresthesia | 1 (0.8%) | 4 (3%) | 0.178 |
| Surgical Site Infection | 1 (0.8%) | 0 (0%) | 0.315 |
| Return to OR | 0 (0%) | 0 (0%) | - |
| Bleeding | 0 (0%) | 0 (0%) | - |
| Mandible fracture, n | 59 | 55 | |
| Malocclusion | 9 (15.3%) | 3 (5.5%) | 0.088 |
| Paresthesia | 3 (5.1%) | 1 (1.8%) | 0.344 |
| Surgical Site Infection | 1 (1.7%) | 1 (1.8%) | 0.960 |
| Return to OR | 1 (1.7%) | 1 (1.8%) | 0.960 |
| Bleeding | 1 (1.7%) | 1 (1.8%) | 0.960 |
| Frontal sinus fracture, n | 30 | 30 | |
| Malocclusion | 0 (0%) | 0 (0%) | - |
| Paresthesia | 0 (0%) | 2 (6.7%) | 0.150 |
| Surgical Site Infection | 0 (0%) | 0 (0%) | - |
| Return to OR | 0 (0%) | 0 (0%) | - |
| Bleeding | 0 (0%) | 0 (0%) | - |
| Nasal bone/septum fracture, n | 202 | 212 | |
| Malocclusion | 0 (0%) | 4 (1.9%) | 0.050 |
| Paresthesia | 0 (0%) | 5 (2.4%) | 0.028 |
| Surgical Site Infection | 2 (1%) | 0 (0%) | 0.146 |
| Return to OR | 1 (0.5%) | 0 (0%) | 0.305 |
| Bleeding | 1 (0.5%) | 1 (0.5%) | 0.973 |
| Zygomatic fracture, n | 87 | 87 | |
| Malocclusion | 2 (2.3%) | 3 (3.4%) | 0.650 |
| Paresthesia | 2 (2.3%) | 4 (4.6%) | 0.406 |
| Surgical Site Infection | 0 (0%) | 0 (0%) | - |
| Return to OR | 0 (0%) | 1 (1.1%) | 0.316 |
| Bleeding | 0 (0%) | 1 (1.1%) | 0.316 |
| Maxillary sinus fracture, n | 141 | 142 | |
| Malocclusion | 3 (2.1%) | 3 (2.1%) | 0.993 |
| Paresthesia | 2 (1.4%) | 4 (2.8%) | 0.414 |
| Surgical Site Infection | 2 (1.4%) | 0 (0%) | 0.154 |
| Return to OR | 1 (0.7%) | 0 (0%) | 0.315 |
| Bleeding | 1 (0.7%) | 0 (0%) | 0.315 |
| LeFort I, n | 7 | 11 | |
| Malocclusion | 0 (0%) | 0 (0%) | - |
| Paresthesia | 0 (0%) | 0 (0%) | - |
| Surgical Site Infection | 1 (14.3%) | 0 (0%) | 0.197 |
| Return to OR | 1 (14.3%) | 0 (0%) | 0.197 |
| Bleeding | 1 (14.3%) | 0 (0%) | 0.197 |
| LeFort II, n | 10 | 14 | |
| Malocclusion | 0 (0%) | 2 (14.3%) | 0.212 |
| Paresthesia | 0 (0%) | 1 (7.1%) | 0.388 |
| Surgical Site Infection | 2 (20.0%) | 0 (0%) | 0.081 |
| Return to OR | 1 (10.0%) | 0 (0%) | 0.227 |
| Bleeding | 1 (10.0%) | 0 (0%) | 0.227 |
| LeFort III, n | 15 | 10 | |
| Malocclusion | 0 (0%) | 0 (0%) | - |
| Paresthesia | 0 (0%) | 2 (20.0%) | 0.071 |
| Surgical Site Infection | 1 (6.7%) | 0 (0%) | 0.405 |
| Return to OR | 0 (0%) | 0 (0%) | - |
| Bleeding | 0 (0%) | 0 (0%) | - |
ENT = Otolaryngology consult, PS = Plastic Surgery consult, OR = operating room.